This update was written automatically with AI from market data and news wire reports, and published without review by a person.
The Dow Jones Industrial Average (^DJI) was down 324.16 (-0.6187%) points today, trading at 52,065.59, as the massive post-election "Trump Trade" rally finally showed signs of exhaustion. Investors shifted their focus toward upcoming Consumer Price Index (CPI) data and hawkish commentary from Federal Reserve officials, leading to a broad pullback in cyclical sectors. Dow Futures (YM=F) also signaled continued pressure, as they were down 383.00 (-0.7296%) points. The primary narrative driving the market is a cautious repositioning ahead of tomorrow’s inflation report, which will likely dictate whether the central bank continues its path of interest rate cuts in December.
Leading the few gainers in the blue-chip index was 3M (MMM), which was up 3.70% following positive sentiment regarding its ongoing restructuring efforts. Tech giant Nvidia (NVDA) also showed resilience, as it was up 1.77% to $225.00, while healthcare leader Johnson & Johnson (JNJ) was up 1.61%. Other notable gainers included Cisco Systems (CSCO), which was up 1.33%, and UnitedHealth Group (UNH), which was up 1.00%. These defensive gains were not enough to offset the broader selling pressure seen across the industrial and financial sectors.
On the losing side, IBM (IBM) was down 2.42%, leading the decliners as investors rotated out of mature tech holdings. Home Depot (HD) was down 2.14% to $303.84 following a cautious outlook on consumer spending despite beating quarterly expectations earlier in the day. Software firm Salesforce (CRM) was down 1.64%, while Sherwin-Williams (SHW) and American Express (AXP) were down 1.36% and 1.27% respectively. The downward movement in these stocks reflects a growing concern that higher long-term bond yields may persist, potentially dampening corporate earnings growth in the coming quarters.
Automated market updates written with AI from market data and news wire reports, published without human review.